Literature DB >> 15153339

Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells.

Noriko Hironaka1, Kanako Mochida, Naoki Mori, Michiyuki Maeda, Naoki Yamamoto, Shoji Yamaoka.   

Abstract

Adult T-cell leukemia (ATL) is a fatal T-cell malignancy that arises long after infection with human T-cell leukemia virus type I (HTLV-I). We reported previously that nuclear factor-kappaB (NF-kappaB) was constitutively activated in ATL cells, although expression of the viral proteins was barely detectable, including Tax, which was known to persistently activate NF-kappaB. Here we demonstrate that ATL cells that do not express detectable Tax protein exhibit constitutive IkappaB kinase (IKK) activity. Transfection studies revealed that a dominant-negative form of IKK1, and not of IKK2 or NF-kappaB essential modulator (NEMO), suppressed constitutive NF-kappaB activity in ATL cells. This IKK activity was accompanied by elevated expression of p52, suggesting that the recently described noncanonical pathway of NF-kappaB activation operates in ATL cells. We finally show that specific inhibition of NF-kappaB by a super-repressor form of IkappaBalpha (SR-IkappaBalpha) in HTLV-I-infected T cells results in cell death regardless of Tax expression, providing definitive evidence of an essential role for NF-kappaB in the survival of ATL cells. In conclusion, the IKK complex is constitutively activated in ATL cells through a cellular mechanism distinct from that of Tax-mediated IKK activation. Further elucidation of this cellular mechanism should contribute to establishing a rationale for treatment of ATL.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15153339      PMCID: PMC1502096          DOI: 10.1593/neo.3388

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  93 in total

Review 1.  Activators and target genes of Rel/NF-kappaB transcription factors.

Authors:  H L Pahl
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

2.  Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells.

Authors:  R Shibata; M Kawamura; H Sakai; M Hayami; A Ishimoto; A Adachi
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  The generation of nfkb2 p52: mechanism and efficiency.

Authors:  M Heusch; L Lin; R Geleziunas; W C Greene
Journal:  Oncogene       Date:  1999-11-04       Impact factor: 9.867

4.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

Authors:  E Schreiber; P Matthias; M M Müller; W Schaffner
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

5.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.

Authors:  S Jacobson; H Shida; D E McFarlin; A S Fauci; S Koenig
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

6.  Two purified factors bind to the same sequence in the enhancer of mouse MHC class I genes: one of them is a positive regulator induced upon differentiation of teratocarcinoma cells.

Authors:  A Israel; O Yano; F Logeat; M Kieran; P Kourilsky
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

7.  Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.

Authors:  C E Parker; S Daenke; S Nightingale; C R Bangham
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

8.  HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene.

Authors:  K T Jeang; S G Widen; O J Semmes; S H Wilson
Journal:  Science       Date:  1990-03-02       Impact factor: 47.728

9.  Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro.

Authors:  A Tanaka; C Takahashi; S Yamaoka; T Nosaka; M Maki; M Hatanaka
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

10.  HTLV-I uveitis: a distinct clinical entity caused by HTLV-I.

Authors:  M Mochizuki; T Watanabe; K Yamaguchi; K Takatsuki; K Yoshimura; M Shirao; S Nakashima; S Mori; S Araki; N Miyata
Journal:  Jpn J Cancer Res       Date:  1992-03
View more
  31 in total

Review 1.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

2.  A20 targets caspase-8 and FADD to protect HTLV-I-infected cells.

Authors:  Y Saitoh; A Hamano; K Mochida; A Kakeya; M Uno; E Tsuruyama; H Ichikawa; F Tokunaga; A Utsunomiya; T Watanabe; S Yamaoka
Journal:  Leukemia       Date:  2015-10-06       Impact factor: 11.528

Review 3.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

4.  Deregulated expression of CD40 ligand in HTLV-I infection: distinct mechanisms of downregulation in HTLV-I-transformed cell lines and ATL patients.

Authors:  Nicole S Harhaj; Branislava Janic; Juan C Ramos; William J Harrington; Edward W Harhaj
Journal:  Virology       Date:  2007-01-26       Impact factor: 3.616

5.  Human T-Cell Lymphotropic Virus Type 1 Transactivator Tax Exploits the XPB Subunit of TFIIH during Viral Transcription.

Authors:  Christophe Martella; Armelle Inge Tollenaere; Laetitia Waast; Benoit Lacombe; Damien Groussaud; Florence Margottin-Goguet; Bertha Cecilia Ramirez; Claudine Pique
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

6.  Tax 1-independent induction of vascular endothelial growth factor in adult T-cell leukemia caused by human T-cell leukemia virus type 1.

Authors:  Karen M Watters; Jonathan Dean; Virginie Gautier; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

7.  Transcriptional regulation of parathyroid hormone-related protein promoter P2 by NF-kappaB in adult T-cell leukemia/lymphoma.

Authors:  M V P Nadella; W P Dirksen; K S Nadella; S Shu; A S Cheng; J A Morgenstern; V Richard; S A Fernandez; T H Huang; D Guttridge; T J Rosol
Journal:  Leukemia       Date:  2007-06-07       Impact factor: 11.528

8.  BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes.

Authors:  Valeriu B Cismasiu; Javier Duque; Elena Paskaleva; Danielle Califano; Sailaja Ghanta; Howard A Young; Dorina Avram
Journal:  Biochem J       Date:  2009-01-15       Impact factor: 3.857

9.  Long Noncoding RNA ANRIL Supports Proliferation of Adult T-Cell Leukemia Cells through Cooperation with EZH2.

Authors:  Zaowen Song; Wencai Wu; Mengyun Chen; Wenzhao Cheng; Juntao Yu; Jinyong Fang; Lingling Xu; Jun-Ichirou Yasunaga; Masao Matsuoka; Tiejun Zhao
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

10.  Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia.

Authors:  Regina Wan Ju Wong; Phuong Cao Thi Ngoc; Wei Zhong Leong; Alice Wei Yee Yam; Tinghu Zhang; Kaori Asamitsu; Shinsuke Iida; Takashi Okamoto; Ryuzo Ueda; Nathanael S Gray; Takashi Ishida; Takaomi Sanda
Journal:  Blood       Date:  2017-10-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.